Table 1 Details of the disease stage, chemotherapy treatment and disease outcome of the 23 patients within the study

1

II

None

Good

2

II

None

Good

3

II

None

Poor

4

II

None

Good

5

II

None

Good

6

II

None

Poor

7

II

None

Poor

8

II

5FU + Leu

Good

9

III

None

Good

10

III

Fol + 5FU + Oxal + Irin

Poor

11

III

5FU + Leu

Good

12

III

5FU + Leu

Good

13

III

5FU + Leu

Poor

14

III

5FU + Leu

Good

15

III

Fol + 5FU + Oxal

Good

16

III

Fol + 5FU + Oxal

Poor

17

III

5FU + Leu

Good

18

III

Fol + 5FU + Oxal

Poor

19

III

5FU + Leu

Good

20

III

5FU + Leu

Good

21

III

5FU + Leu + Irin + bevacizumab

Poor

22

III

5FU + Leu

Good

23

III

5FU + Leu

Good